| DKK1 |
| LOCUS ID | 22943 | ||||||||||||||||
| GENE_SYMBOL | DKK1 | ||||||||||||||||
| GENE NAME | dickkopf WNT signali | ||||||||||||||||
| SYNONYMNS | SK, DKK-1 | ||||||||||||||||
| CHROMOSOME | 10 | ||||||||||||||||
| HOMOLOGENE ID | 7689 |
| microRNAs | NA | NA |
| GENE SUMMARY |
|---|
| This gene encodes a protein that is a member of the dickkopf family. It is a secreted protein with two cysteine rich regions and is involved in embryonic development through its inhibition of the WNT signaling pathway. Elevated levels of DKK1 in bone marrow plasma and peripheral blood is associated with the presence of osteolytic bone lesions in patients with multiple myeloma. [provided by RefSeq, Jul 2008] |
| OBSERVATIONS |
|---|
| Complication | Evidence | PMID |
| Nephropathy | 1. Knocking down DKK1 prevents diabetes-induced renal dysfunction and microstructure deterioration, suggesting that inhibition of DKK1 offers therapeutic potential for diabetic nephropathy. | 20019166 |
| Cardiovascular | 1. In summary, circulating DKK1 levels are higher in T2DM with CVD and are associated with an abnormal carotid IMT in this cross-sectional study. DKK1 may be involved in vascular disease of T2DM patients | 25369286 |
| Retinopathy | 1. In addition, SK inhibitors were shown to block TNFalpha-induced expression of adhesion proteins, suppress VEGF-induced vascular leakage in an in vivo mouse model, and reduce retinal vascular leakage in the rat diabetic retinopathy model.Overall, these studies demonstrate that inhibitors of SK attenuate the effects of proliferative and inflammatory stimuli on RECs both in vitro and in vivo, and so could be significant therapeutics in the treatment of diabetic retinopathy. 2. Decreased plasma DKK-1 levels, which may contribute to the Wnt pathway activation, are associated with the presence and progression of DR, and have potential to become a biomarker for DR. | 17065523 |